Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors

Endometrial cancer is the leading gynecologic cancer in women in the United States with 52,630 women predicted to be diagnosed with the disease in 2014. The objective of this study was to determine if progesterone (P4) receptor membrane component 1 (PGRMC1) influenced endometrial cancer cell viabili...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Lett
Autori principali: Friel, Anne M., Zhang, Ling, Pru, Cindy A., Clark, Nicole C., McCallum, Melissa L., Blok, Leen J., Shioda, Toshi, Peluso, John J., Rueda, Bo R., Pru, James K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259802/
https://ncbi.nlm.nih.gov/pubmed/25304370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2014.09.036
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi